<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334482</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1297-9716</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Veterinary research</Title><ISOAbbreviation>Vet Res</ISOAbbreviation></Journal><ArticleTitle>Development and characterization of reverse genetics systems of feline infectious peritonitis virus for antiviral research.</ArticleTitle><Pagination><StartPage>124</StartPage><MedlinePgn>124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13567-024-01373-z</ELocationID><Abstract><AbstractText>Feline infectious peritonitis (FIP) is a lethal, immune-mediated disease in cats caused by feline infectious peritonitis virus (FIPV), a biotype of feline coronavirus (FCoV). In contrast to feline enteric coronavirus (FECV), which exclusively infects enterocytes and causes diarrhea, FIPV specifically targets macrophages, resulting in the development of FIP. The transmission and infection mechanisms of this complex, invariably fatal disease remain unclear, with no effective vaccines or approved drugs for its prevention or control. In this study, a full-length infectious cDNA clone of the wild-type FIPV WSU79-1149 strain was constructed to generate recombinant FIPV (rFIPV-WT), which exhibited similar growth kinetics and produced infectious virus titres comparable to those of the parental wild-type virus. In addition, the superfold green fluorescent protein (msfGFP) and Renilla luciferase (Rluc) reporter genes were incorporated into the rFIPV-WT cDNA construct to generate reporter rFIPV-msfGFP and rFIPV-Rluc viruses. While the growth characteristics of the rFIPV-msfGFP virus were similar to those of its parental rFIPV-WT, the rFIPV-Rluc virus replicated more slowly, resulting in the formation of smaller plaques than did the rFIPV-WT and rFIPV-msfGFP viruses. In addition, by replacing the S, E, M, and ORF3abc genes with msfGFP and Rluc genes, the replicon systems repFIPV-msfGFP and repFIPV-Rluc were generated on the basis of the cDNA construct of rFIPV-WT. Last, the use of reporter recombinant viruses and replicons in antiviral screening assays demonstrated their high sensitivity for quantifying the antiviral effectiveness of the tested compounds. This integrated system promises to significantly streamline the investigation of virus replication within host cells, enabling efficient screening for anti-FIPV compounds and evaluating emerging drug-resistant mutations within the FIPV genome.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gu</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fung</LastName><ForeName>To Sing</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Wong Tsz</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osterrieder</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institut Für Virologie, Freie Universität Berlin, 14163, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go</LastName><ForeName>Yun Young</ForeName><Initials>YY</Initials><Identifier Source="ORCID">0000-0003-0907-2265</Identifier><AffiliationInfo><Affiliation>College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea. yunygo@konkuk.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023-A019-0304</GrantID><Agency>Konkuk University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vet Res</MedlineTA><NlmUniqueID>9309551</NlmUniqueID><ISSNLinking>0928-4249</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016765" MajorTopicYN="Y">Coronavirus, Feline</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059386" MajorTopicYN="Y">Reverse Genetics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016766" MajorTopicYN="Y">Feline Infectious Peritonitis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feline infectious peritonitis virus</Keyword><Keyword MajorTopicYN="N">antiviral compounds</Keyword><Keyword MajorTopicYN="N">high-content screening</Keyword><Keyword MajorTopicYN="N">recombinant viruses</Keyword><Keyword MajorTopicYN="N">replicon</Keyword><Keyword MajorTopicYN="N">reverse genetics</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334482</ArticleId><ArticleId IdType="pmc">PMC11438400</ArticleId><ArticleId IdType="doi">10.1186/s13567-024-01373-z</ArticleId><ArticleId IdType="pii">10.1186/s13567-024-01373-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Woo PCY, de Groot RJ, Haagmans B, Lau SKP, Neuman BW, Perlman S, Sola I, van der Hoek L, Wong ACP, Yeh SH (2023) ICTV virus taxonomy profile: coronaviridae 2023. J Gen Virol 104:001843</Citation><ArticleIdList><ArticleId IdType="pubmed">37097842</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekes G, Thiel HJ (2016) Feline coronaviruses: pathogenesis of feline infectious peritonitis. Adv Virus Res 96:193–218</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112361</ArticleId><ArticleId IdType="pubmed">27712624</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Liu Q, Kong F, Guo D, Zhai J, Su M, Sun D (2019) Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP-suspected cats in China. Transbound Emerg Dis 66:763–775</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7168551</ArticleId><ArticleId IdType="pubmed">30468573</ArticleId></ArticleIdList></Reference><Reference><Citation>Benetka V, Kubber-Heiss A, Kolodziejek J, Nowotny N, Hofmann-Parisot M, Mostl K (2004) Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol 99:31–42</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7117137</ArticleId><ArticleId IdType="pubmed">15019109</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer A, Siti Suri A, Abdul Rahman O, Mohd HB, Faruku B, Saeed S, Tengku Azmi TI (2012) Isolation and molecular characterization of type I and type II feline coronavirus in Malaysia. Virol J 9:278</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3568730</ArticleId><ArticleId IdType="pubmed">23171743</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ, de Groot RJ (1998) Feline coronavirus type II strains 79–1683 and 79–1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 72:4508–4514</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109693</ArticleId><ArticleId IdType="pubmed">9557750</ArticleId></ArticleIdList></Reference><Reference><Citation>Dye C, Siddell SG (2005) Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J Gen Virol 86:2249–2253</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583351</ArticleId><ArticleId IdType="pubmed">16033972</ArticleId></ArticleIdList></Reference><Reference><Citation>Haijema BJ, Volders H, Rottier PJ (2004) Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol 78:3863–3871</Citation><ArticleIdList><ArticleId IdType="pmc">PMC374255</ArticleId><ArticleId IdType="pubmed">15047802</ArticleId></ArticleIdList></Reference><Reference><Citation>Rottier PJ, Nakamura K, Schellen P, Volders H, Haijema BJ (2005) Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol 79:14122–14130</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1280227</ArticleId><ArticleId IdType="pubmed">16254347</ArticleId></ArticleIdList></Reference><Reference><Citation>Vennema H, Poland A, Foley J, Pedersen NC (1998) Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 243:150–157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7131759</ArticleId><ArticleId IdType="pubmed">9527924</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HW, Egberink HF, Halpin R, Spiro DJ, Rottier PJ (2012) Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis 18:1089–1095</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376813</ArticleId><ArticleId IdType="pubmed">22709821</ArticleId></ArticleIdList></Reference><Reference><Citation>Licitra BN, Millet JK, Regan AD, Hamilton BS, Rinaldi VD, Duhamel GE, Whittaker GR (2013) Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg Infect Dis 19:1066–1073</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3713968</ArticleId><ArticleId IdType="pubmed">23763835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bank-Wolf BR, Stallkamp I, Wiese S, Moritz A, Tekes G, Thiel HJ (2014) Mutations of 3c and spike protein genes correlate with the occurrence of feline infectious peritonitis. Vet Microbiol 173:177–188</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7117521</ArticleId><ArticleId IdType="pubmed">25150756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CS, Porter E, Matthews D, Kipar A, Tasker S, Helps CR, Siddell SG (2015) Genotyping coronaviruses associated with feline infectious peritonitis. J Gen Virol 96:1358–1368</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635486</ArticleId><ArticleId IdType="pubmed">25667330</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaimes JA, Whittaker GR (2018) Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function. Virology 517:108–121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112122</ArticleId><ArticleId IdType="pubmed">29329682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang H, Liu J, Yin Y, Cao S, Yan R, Ren Y, Zhou D, Li Q, Li J, Liao X, Ji W, Du B, Si Y, Hu C (2022) Epidemiology and comparative analyses of the S gene on feline coronavirus in central China. Pathogens 11:460</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9031646</ArticleId><ArticleId IdType="pubmed">35456135</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K, Chang HW, Rottier PJM (2018) Differential susceptibility of macrophages to serotype II feline coronaviruses correlates with differences in the viral spike protein. Virus Res 255:14–23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114831</ArticleId><ArticleId IdType="pubmed">29936068</ArticleId></ArticleIdList></Reference><Reference><Citation>Balint A, Farsang A, Zadori Z, Hornyak A, Dencso L, Almazan F, Enjuanes L, Belak S (2012) Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies of the role of ORF3abc in viral cell tropism. J Virol 86:6258–6267</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372193</ArticleId><ArticleId IdType="pubmed">22438554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HW, Egberink HF, Rottier PJ (2011) Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg Infect Dis 17:744–746</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3377428</ArticleId><ArticleId IdType="pubmed">21470478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen NC, Liu H, Scarlett J, Leutenegger CM, Golovko L, Kennedy H, Kamal FM (2012) Feline infectious peritonitis: role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats. Virus Res 165:17–28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114484</ArticleId><ArticleId IdType="pubmed">22280883</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HW, de Groot RJ, Egberink HF, Rottier PJ (2010) Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol 91:415–420</Citation><ArticleIdList><ArticleId IdType="pubmed">19889934</ArticleId></ArticleIdList></Reference><Reference><Citation>Myrrha LW, Silva FMF, Vidigal PMP, Resende M, Bressan GC, Fietto JLR, Santos MR, Silva LMN, Assao VS, Silva-Ju Nior A, de Almeida MR (2019) Feline coronavirus isolates from a part of Brazil: insights into molecular epidemiology and phylogeny inferred from the 7b gene. J Vet Med Sci 81:1455–1460</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6863716</ArticleId><ArticleId IdType="pubmed">31447457</ArticleId></ArticleIdList></Reference><Reference><Citation>Vennema H, Rossen JW, Wesseling J, Horzinek MC, Rottier PJ (1992) Genomic organization and expression of the 3’ end of the canine and feline enteric coronaviruses. Virology 191:134–140</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7131216</ArticleId><ArticleId IdType="pubmed">1329312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H, Gu H, Kang H, Jia H (2023) Development of a rapid reverse genetics system for feline coronavirus based on TAR cloning in yeast. Front Microbiol 14:1141101</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10076789</ArticleId><ArticleId IdType="pubmed">37032894</ArticleId></ArticleIdList></Reference><Reference><Citation>Terada Y, Kuroda Y, Morikawa S, Matsuura Y, Maeda K, Kamitani W (2019) Establishment of a virulent full-length cDNA clone for type I feline coronavirus strain C3663. J Virol 93:e01208-19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6803248</ArticleId><ArticleId IdType="pubmed">31375588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehmann R, Kristen-Burmann C, Bank-Wolf B, Konig M, Herden C, Hain T, Thiel HJ, Ziebuhr J, Tekes G (2018) Reverse genetics for type I feline coronavirus field isolate to study the molecular pathogenesis of feline infectious peritonitis. mBio 9:e01422-18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6069117</ArticleId><ArticleId IdType="pubmed">30065095</ArticleId></ArticleIdList></Reference><Reference><Citation>Haijema BJ, Volders H, Rottier PJ (2003) Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol 77:4528–4538</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152114</ArticleId><ArticleId IdType="pubmed">12663759</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Hu G, Liang R, Shi J, Qiu X, Yang Y, Jiao Z, Chen Y, Shen Z, Li M, Shi Y, Mao J, Peng G (2021) Establishment of full-length cDNA clones and an efficient oral infection model for feline coronavirus in cats. J Virol 95:e0074521</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513462</ArticleId><ArticleId IdType="pubmed">34406859</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekes G, Hofmann-Lehmann R, Stallkamp I, Thiel V, Thiel HJ (2008) Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol 82:1851–1859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2258703</ArticleId><ArticleId IdType="pubmed">18077720</ArticleId></ArticleIdList></Reference><Reference><Citation>V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V (2021) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19:155–170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HT, Falzarano D, Gerdts V, Liu Q (2021) Construction of a noninfectious SARS-CoV-2 replicon for antiviral-drug testing and gene function studies. J Virol 95:e0068721</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387049</ArticleId><ArticleId IdType="pubmed">34191580</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Hu BJ, Zhao K, Luo Y, Lin HF, Shi ZL (2021) Development of A MERS-CoV replicon cell line for antiviral screening. Virol Sin 36:730–735</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898024</ArticleId><ArticleId IdType="pubmed">33616893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Song W, Chen S, Yuan Z, Yi Z (2021) A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2. Antivir Res 185:104974</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670965</ArticleId><ArticleId IdType="pubmed">33217430</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Chou CK, Wu WW, Luan B, Wang TT (2022) Stable cell clones harboring self-replicating SARS-CoV-2 RNAs for drug screen. J Virol 96:e0221621</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8941906</ArticleId><ArticleId IdType="pubmed">35080424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS (2003) Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA 100:12995–13000</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240733</ArticleId><ArticleId IdType="pubmed">14569023</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, Liu J, Schindewolf C, Bopp NE, Aguilar PV, Plante KS, Weaver SC, Makino S, LeDuc JW, Menachery VD, Shi PY (2020) An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27:841-848.e3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153529</ArticleId><ArticleId IdType="pubmed">32289263</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Shao Y, Guo Z, Ni Y, Sun X, Leung AYH, Li R (2024) Giraffe: a tool for comprehensive processing and visualization of multiple long-read sequencing data. bioRxiv:2024.2005.2010.593289</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11393587</ArticleId><ArticleId IdType="pubmed">39279873</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilm A, Aw PP, Bertrand D, Yeo GH, Ong SH, Wong CH, Khor CC, Petric R, Hibberd ML, Nagarajan N (2012) LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 40:11189–11201</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3526318</ArticleId><ArticleId IdType="pubmed">23066108</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY (2020) Evasion of type I interferon by SARS-CoV-2. Cell Rep 33:108234</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Thi Nhu Thao T, Labroussaa F, Ebert N, V’Kovski P, Stalder H, Portmann J, Kelly J, Steiner S, Holwerda M, Kratzel A, Gultom M, Schmied K, Laloli L, Husser L, Wider M, Pfaender S, Hirt D, Cippa V, Crespo-Pomar S, Schroder S, Muth D, Niemeyer D, Corman VM, Muller MA, Drosten C, Dijkman R, Jores J, Thiel V (2020) Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature 582:561–565</Citation><ArticleIdList><ArticleId IdType="pubmed">32365353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ (2020) The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J Virol 94:e01246-20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7654266</ArticleId><ArticleId IdType="pubmed">32938769</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing N, Wang Z, Wang J, Nascimento M, Jongkaewwattana A, Trimpert J, Osterrieder N, Kunec D (2022) Engineering and characterization of avian coronavirus mutants expressing fluorescent reporter proteins from the replicase gene. J Virol 96:e0065322</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9327687</ArticleId><ArticleId IdType="pubmed">35862676</ArticleId></ArticleIdList></Reference><Reference><Citation>Almazan F, Sola I, Zuniga S, Marquez-Jurado S, Morales L, Becares M, Enjuanes L (2014) Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res 189:262–270</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4727449</ArticleId><ArticleId IdType="pubmed">24930446</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H, Fang SG, Chen B, Chen G, Tay FP, Liu DX (2009) Towards construction of viral vectors based on avian coronavirus infectious bronchitis virus for gene delivery and vaccine development. J Virol Methods 160:48–56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112882</ArticleId><ArticleId IdType="pubmed">19409420</ArticleId></ArticleIdList></Reference><Reference><Citation>de Haan CA, Haijema BJ, Boss D, Heuts FW, Rottier PJ (2005) Coronaviruses as vectors: stability of foreign gene expression. J Virol 79:12742–12751</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1235832</ArticleId><ArticleId IdType="pubmed">16188977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SG, Kim DY, Hyun BH, Bae YS (2002) Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system. J Virol 76:1649–1662</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135903</ArticleId><ArticleId IdType="pubmed">11799160</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel V, Herold J, Schelle B, Siddell SG (2001) Viral replicase gene products suffice for coronavirus discontinuous transcription. J Virol 75:6676–6681</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114390</ArticleId><ArticleId IdType="pubmed">11413334</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel Y, Gluck A, Nachshon A, Winkler R, Fisher T, Rozman B, Mizrahi O, Lubelsky Y, Zuckerman B, Slobodin B, Yahalom-Ronen Y, Tamir H, Ulitsky I, Israely T, Paran N, Schwartz M, Stern-Ginossar N (2021) SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature 594:240–245</Citation><ArticleIdList><ArticleId IdType="pubmed">33979833</ArticleId></ArticleIdList></Reference><Reference><Citation>Züst R, Cervantes-Barragán L, Kuri T, Blakqori G, Weber F, Ludewig B, Thiel V (2007) Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog 3:1062–1072</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1941747</ArticleId><ArticleId IdType="pubmed">17696607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wathelet MG, Orr M, Frieman MB, Baric RS (2007) Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol 81:11620–11633</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2168762</ArticleId><ArticleId IdType="pubmed">17715225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei L, Ying S, Baojun L, Yi Y, Xiang H (2014) Attenuation of mouse hepatitis virus by deletion of the LLRKxGxKG region of Nsp1. PLoS One 8:e61166</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3620170</ArticleId><ArticleId IdType="pubmed">23593419</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M, Kratzat H, Hayn M, Mackens-Kiani T, Cheng J, Straub JH, Sturzel CM, Frohlich T, Berninghausen O, Becker T, Kirchhoff F, Sparrer KMJ, Beckmann R (2020) Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 369:1249–1255</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Zhang GX, Yang YL, Li MX, Yang SQ, Peng GQ (2021) Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression. J Gen Virol 102:jgv001513</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116783</ArticleId><ArticleId IdType="pubmed">33151142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapointe CP, Grosely R, Johnson AG, Wang J, Fernandez IS, Puglisi JD (2021) Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation. Proc Natl Acad Sci USA 118:e2017715118</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8017934</ArticleId><ArticleId IdType="pubmed">33479166</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Wang G, Yang YL, Shi JL, Fang LR, Li F, Xiao SB, Fu ZF, Peng GQ (2019) A conserved region of nonstructural protein 1 from alphacoronaviruses inhibits host gene expression and is critical for viral virulence. J Biol Chem 294:13606–13618</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6746460</ArticleId><ArticleId IdType="pubmed">31350335</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmied K, Ehmann R, Kristen-Burmann C, Ebert N, Barut GT, Almeida L, Kelly JN, Thomann L, Stalder H, Lang R, Tekes G, Thiel V (2024) An RNA replicon system to investigate promising inhibitors of feline coronavirus. J Virol 98:e0121623</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10878086</ArticleId><ArticleId IdType="pubmed">38236006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipar A, Meli ML (2014) Feline infectious peritonitis: still an enigma? Vet Pathol 51:505–526</Citation><ArticleIdList><ArticleId IdType="pubmed">24569616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao Z, Wang PP, Hu XS, Chen YX, Xu J, Zhang JT, Wu BY, Luo RX, Shi YJ, Peng GQ (2024) Feline infectious peritonitis virus ORF7a is a virulence factor involved in inflammatory pathology in cats. Antivir Res 222:105794</Citation><ArticleIdList><ArticleId IdType="pubmed">38176470</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie XP, Zou J, Shan C, Yang YJ, Kum DB, Dallmeier K, Neyts J, Shi PY (2016) Zika virus replicons for drug discovery. EBioMedicine 12:156–160</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5078599</ArticleId><ArticleId IdType="pubmed">27658737</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi PY, Tilgner M, Lo MK (2002) Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 296:219–233</Citation><ArticleIdList><ArticleId IdType="pubmed">12069521</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, Kamitani W, DeDiego ML, Enjuanes L, Matsuura Y (2012) Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. J Virol 86:11128–11137</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3457165</ArticleId><ArticleId IdType="pubmed">22855488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D (2009) Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci USA 106:3484–3489</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2651275</ArticleId><ArticleId IdType="pubmed">19208801</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Ouyang M, Yu T, Zhuang J, Wang W, Liu X, Duan F, Guo D, Peng X, Pan JA (2022) Genome-wide analysis of the indispensable role of non-structural proteins in the replication of SARS-CoV-2. Front Microbiol 13:907422</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198553</ArticleId><ArticleId IdType="pubmed">35722274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>